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The Role of the Fifth Subunit on Sensitivity of a4b2-Containing Nicotinic
Acetylcholine Receptors to Allosteric Modulators
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a4b2 nicotinic acetylcholine receptors (nAChRs) belong to the family of pen-
tameric ligand gated ion channels, which includes muscle nAChRs, 5-HT3,
GABA receptors type A and C, and glycine receptors. a4b2 nAChRs are
the predominant heteromeric nAChR in the brain. The a4b2 nAChR is the
predominant nAChR subtype in the brain. Here, it constitutes one of the
most important modulatory receptor systems influencing activities such as
cognition, mood, consciousness and nociception and converging evidence in-
dicates that this type is a key mediator of the rewarding and reinforcing ef-
fects of nicotine. a4 and b2 nAChR subunits assemble into alternate
stoichiometries (a4b2)2a4 and (a4b2)2b2 that display remarkable differing
sensitivity to activation by agonists and allosteric modulators (Moroni et
al., 2006; Carbone et al., 2009). Positive allosteric modulators of a4b2
nAChRs have attracted considerable interest as potential tools for the treat-
ment of cognitive impairment, chronic pain and depression, and as an aid
for smoking cessation. However, despite the therapeutic potential of these
types of compounds, it is not yet know the structural elements determining
stoichiometry-specific sensitivity to a4b2 nAChR allosteric modulators.
Here, we have used fully concatenated (a4b2)2a4, (a4b2)2b2 and (a4b2)
2a5 nAChRs in combination with chimeric receptors, single point mutations
and homology models of the alternate a4b2 nAChRs to determine the effects
of desformylflustrabromine (dFBr), a selective positive allosteric modulator of
a4b2 nAChR, on a4b2nAChRs and structural elements responsible for those
effects. We show that dFBr effects are receptor stoichiometry-dependent and
that the fifth subunits is a major determinant of the potentiating effects of
dFBr.
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We have identified several distinct mechanisms by which inhibitors of tyro-
sine kinases (genistein) and calcineurin/PP2B (cyclosporine A, CsA) produce
functional upregulation of a7 Rs expressed in Xenopus oocytes. These ef-
fects varied with the duration of drug exposure and time course of expres-
sion. Genistein’s potentiation of peak currents was greater early in
expression (2 vs. 5 days following a7-cRNA injection), and for prolonged
drug exposures (24 hr vs 1 min). CsA’s potentiation was limited to 24 hr
exposure and was independent of expression time. When combined 5-days
post-injection, genistein and CsA produced a facilitation greater than either
alone: 5-6 fold for CsA þ 1 min genistein vs. 2.6-fold for CsA and 2.3-
fold for 1 min genistein; 8.5 fold for CsA þ 24 hr genistein vs. 2.6 fold
for CsA and 4.3 fold for 24 hr genistein. Similarly, 2-days following
cRNA injections, 24 hr CsA plus 1 min genistein produced facilitation
greater than either alone: 4.5 fold vs. 1.5 for CsA and 2.8 for genistein.
However, the combination of CsA and genistein (24 hr) produced facilitation
(5.3 fold) that was less than genistein alone: 1.5 for CsA, and 12 for genis-
tein. We propose a model to explain this pattern that assumes: 1) 1 min gen-
istein’s effects are exclusively PAM, while 24 hr genistein’s effects are PAM
and non-PAM (all effects are positive), 2) the effects of CsA alone are net
positive, but reflect two opposing processes. CsA facilitates currents by
increasing surface membrane numbers of a7-Rs and/or single-channel gating.
But CsA also inhibits cRNA-translation and/or chaperoning of a7-Rs. The
inhibitory effect is greater early in expression, reducing the number of func-
tional a7-Rs distal to the ER/Golgi pathway that genistein can positively
interact with.
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The nicotinic acetylcholine receptor (nAChR) is involved with regulating the
release of neurotransmitter in the synapse. This research focuses on two sub-types of neuronal nAChR, the a6b2 and a4b2 receptors. Subtypes containing
the a6 and b2 subunits are found mainly in dopaminergic neurons. The acetyl-
choline binding site in these subtypes, which sits at the interface of the two sub-
units, is an important therapeutic target. Expression and activation of a pure
population of a6b2 receptors in X. laevis oocytes has previously never been re-
ported. This study used two mutations in the b2M3-M4 loop and a reporter mu-
tation in the M2 helix of each subunit to successfully express a6b2 receptors.
Expression has been optimized, and a method to control subunit stoichiometry
has been developed. We then used unnatural amino acid mutagenesis to
develop a binding model for acetylcholine and nicotine at the a6-b2 subunit
interface.
The a4b2 subtype is the most prevalent nAChR subtype found in the brain and
is implicated in many neurological disorders. Previous work has established a
hydrogen bond interaction between the pyrrolidine nitrogen of nicotine and the
carbonyl backbone adjacent to Trp149 in the a4 subunit. N’-methylnicotinium,
which has a quaternary amine at the pyrrolidine nitrogen and cannot donate a
hydrogen bond, was synthesized in order to probe this hydrogen bond donating
interaction. Through a double-mutant cycle analysis utilizing an a-hydroxy
acid mutation to perturb the carbonyl backbone hydrogen bond acceptor, we
have determined that the hydrogen bonding interaction has a coupling energy
of ~2 kcal/mol.
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Neuronal Nicotinic acetylcholine receptors (nAChRs) are found throughout
the brain and have vital roles in memory and learning. In addition, these ligand
gated ion channel are major targets of drug research for neurological disorders.
Here, the two stoichiometries of a4b2 nAChRs expressed in Xenopus oocytes
were probed using two agonists that display stoichiometry selectivity:
Sazetidine A and NS9283. The results from these studies led to the following
conclusions that may be generalized to the nAChR family: 1) an agonist must
be bound to each a subunit in the receptor in order to fully activate the receptor
and 2) three key residues located on the complementary side of the subunit
dictate agonist selectivity. Through better understanding of agonist binding,
more potent and selective responses with minimized off target responses can
be obtained.
1728-Pos Board B458
Insights into the Distinctly Different Sensitivities of a7 and a7b2 nAChRs
to the Volatile Anesthetic Isoflurane
David D. Mowrey1, Qiang Liu2, Vasyl Bondarenko3, Qiang Chen3,
Edom Seyoum3, Yan Xu3, Jie Wu2, Pei Tang3.
1Computational Biology, University of Pittsburgh, Pittsburgh, PA, USA,
2Division of Neurology, Barrow Neurological Institute, St Joseph’s Hospital
and Medical Center, Phoenix, AZ, USA, 3Anesthesiology, University of
Pittsburgh, Pittsburgh, PA, USA.
Nicotinic acetylcholine receptors (nAChRs) mediate the fast synaptic transmis-
sion in the central and peripheral nervous systems. They are also targets of gen-
eral anesthetics. Among the nAChR subtypes, a7 and a4b2 nAChRs are the
most abundant subtypes found in the brain. Despite their high sequence homol-
ogy, the a4b2 nAChR is hypersensitive but the a7 nAChR is insensitive to vol-
atile general anesthetics. The underlying cause for the functional discrepancy
between these homologous receptors presents an intriguing enigma. In this
study, we have found that the a7b2 nAChR is hypersensitive to the volatile
anesthetic isoflurane and that the b2 subunit is primarily responsible for confer-
ring anesthetic sensitivity. Using high-resolution NMR, we identified intrasu-
bunit isoflurane binding sites at the extracellular and intracellular ends of the
b2 and a7 transmembrane domains, respectively. Cavity analyses revealed
that b2, but not a7, has a pocket large enough to accommodate isoflurane bind-
ing to the extracellular end of the transmembrane domain. Variations in pocket
size result from subtle structural differences between b2 and a7, where the
angle between the TM2 and TM4 helices differs by ~7 between b2 and a7.
While isoflurane binding perturbed dynamics for both b2 and a7, only the bind-
ing to the extracellular end of the b2 transmembrane domain produced signif-
icant dynamics changes for the pore-lining residues. The study suggests that a
subtle structural difference could affect drug binding. Furthermore, only the
drug binding that affects the dynamics of the channel gate is able to generate
the functional effect. Supported by NIH (R01GM66358, R01GM56257, and
R37GM049202).
